Attention Deficit Hyperactivity Disorder. Disturbance of activity and attention
Conditions
Interventions
Intervention 1: Intervention 1: buspirone was initiated with 0/5 mg/kg/day to maximum 45mg/day. Intervention 2: Intervention 2: Methylphenidate was initiated with 0/5-1 mg/kg/day and adjusted to maxim
Treatment - Drugs
Intervention 1: buspirone was initiated with 0/5 mg/kg/day to maximum 45mg/day.
Intervention 2: Methylphenidate was initiated with 0/5-1 mg/kg/day and adjusted to maximum 60 mg per day
Sponsors
Neuroscience Research Center Kerman University of Medical Sciences, Kerman ,Iran
Eligibility
Sex/Gender
All
Age
6 Years to 16 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: ADHD diagnosis according to DSM-IV-TR criteria that scored above 20 in ADHD-Rating Scale. Exclusion criteria: evidence of a mental retardation(IQ<70) or a major psychiatric problem other than oppositional defiant disorder and conduct disorder or receiving any psychotropic medication through 2 weeks before initiating treatment; medical disorders that would preclude the safe use of methylphenidate or buspirone.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hyperactivity, impulsivity and inattention symptoms according to parent and teacher point of view. Timepoint: every 2 weeks. Method of measurement: ADHD Rating Scale(parent and teacher form). | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects include increase or decrease of appetite,weight and sleep,tic,stomachach. Timepoint: every 2 weeks. Method of measurement: Checklist of each drug side effects. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mahin Eslami Sharbabaki
Kerman University of Medical Sciences
Outcome results
None listed